Tech Company Financing Transactions
Tethys Bioscience Funding Round
Tethys Bioscience closed a $33 million venture capital round on 7/21/2010. Backers included Aeris Capital AG, Greenspring Global Partners and Kleiner Perkins Caufield & Byers.
Transaction Overview
Company Name
Announced On
7/21/2010
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$33,000,000
Round
Undisclosed
Investors
Proceeds Purpose
These proceeds will support expanded commercialization of the Tethys PreDx� Diabetes Risk Score (DRS), a simple-to-use, multimarker blood test that enables accurate identification of patients who have a high risk of developing type 2 diabetes within five years.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5858 Horton St. 280
Emeryville, CA 94608
USA
Emeryville, CA 94608
USA
Phone
Website
Email Address
Overview
The company has become a pioneer in the discovery, development and value creation of novel biological markers for the clinical diagnostics marketplace: Biomarkers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tonya Mallory
Chief Information Officer
Nuno Valentine
Chief Medical Officer
Tara Dall
Chief Scientific Officer
Russell Warnick
Chief Technical Officer
Michael Woodard
Co-Founder
Joseph McConnell
VP - Bus. Development
Joe Anastasia
VP - Marketing
Paul Spicer
Browse more venture capital transactions:
Prev: 7/21/2010: Gist venture capital transaction
Next: 7/21/2010: Flipboard venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs